Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 17Terminated 3Recruiting 3Active not recruiting 2

Sponsor Class

NIH 5OTHER 4NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Gynecologic 1

Conditions

Solid Tumors 1Ovarian Neoplasms 1

Interventions

pembrolizumab 184Carboplatin 132Cisplatin 102Paclitaxel 101Gemcitabine 86Pemetrexed 79durvalumab 75Nivolumab 67Docetaxel 55atezolizumab 51Cyclophosphamide 49Bevacizumab 49Dexamethasone 45Capecitabine 45Oxaliplatin 42130-nm albumin-bound paclitaxel 41Rituximab 40Fulvestrant 39Lenalidomide 38Fluorouracil 37Prednisone 32osimertinib 31olaparib 29venetoclax 28fludarabine 28Leucovorin 28Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × ipatasertib × Clear all
NCT04931342 2026-06-08

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting
176 enrolled
Gynecologic

Ovarian Neoplasms

NCT04589845 2026-05-08

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Hoffmann-La Roche

Phase 2 Active not recruiting
920 enrolled 1 FDA
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡